Statins may increase risk of diabetes by 46 percent
the ONA take:
The use of statins is associated with a 46% increase in the risk of developing diabetes, a new study published in the journal Diabetologia has shown.
For the study, researchers from the University of Eastern Finland and Kuopio University Hospital in Finland sought to investigate the effects of statin treatment on the risk of type 2 diabetes and blood sugar control in non-diabetic men that participated in the 6-year follow-up of the Metabolic Syndrome in Men (METSIM) study.
Among the 8,749 participants, 625 were diagnosed with new diabetes during the 5.9-year followw-up period.
Results showed that after adjusting for confounding factors, such as BMI, physical activity, alcohol intake, smoking, and beta-blocker and diuretic use, patients who took statins were 46% more likely to develop diabetes compared with those who were not treated with diabetes.
Researchers found that the high-dose simvastatin was associated with a 46% increased risk of developing diabetes compared with 28% increased risk for low-dose simvastatin. High-dose atorvastatin was associated with a 37% increased risk.
The use of statins is associated with a 46% increase in the risk of developing diabetes.
Sign Up for Free e-newsletters
- Triplet Regimen Found Most Effective for Relapsed/Refractory Multiple Myeloma
- Integrating Preoperative Oral Care Into Cancer Treatment Plans
- Current Status and Dilemma of Second-line Treatment in Advanced Pancreatic Cancer: Is There a Silver Lining?
- American Association for Cancer Research Releases Its 2018 Annual Report
- Pulmonary Toxicity Increased in Pediatric Hodgkin Lymphoma Treated With Brentuximab Vedotin
- Benefit of Chemotherapy for Breast Cancer Observed With Midrange Gene Assay Score
- Antioxidant Interaction With Cancer Therapy
- Young Survivors of Breast Cancer Report Sexual Quality of Life Declines After Treatment
- Myeloablative Conditioning Effective in AML Secondary to MDS/MPN Prior to Allogeneic HCT
- Insurance Status Influences Overall Survival in Follicular Lymphoma
- Skin Cancer Screening: Are They Effective?
- Metronidazole, Vancomycin Recommended for C Difficile in Pediatric Oncology, HSCT
- CDC: HPV Vaccination Rates on the Rise Among Adolescents
- High-Dose vs Standard-Dose Flu Vaccine in Elderly Receiving Chemotherapy
- FDA Grants Approval to Novel Treatment for Hairy Cell Leukemia
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|